IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA panel OKs testing of pain drugs linked to bone loss

By Rachael Rettner
MyHealthNewsDaily



as anti-nerve growth factor (anti-NGF) drugs



osteoarthritis arthritis



More from MyHealthNewsDaily:

More from Vitals: